Literature DB >> 34997317

SOX2-OT induced by PAI-1 promotes triple-negative breast cancer cells metastasis by sponging miR-942-5p and activating PI3K/Akt signaling.

Wenwen Zhang1, Shuofei Yang2, Datian Chen3, Daolu Yuwen4, Juan Zhang4, Xiaowei Wei4, Xin Han5, Xiaoxiang Guan6,7.   

Abstract

Triple-negative breast cancer (TNBC) has an aggressive biological behavior and poor outcome. Our published study showed that PAI-1 could induce the migration and metastasis of TNBC cells. However, the underlying mechanism by which PAI-1 regulates TNBC metastasis has not been addressed. Here, we demonstrated that PAI-1 is high expressed in TNBC and promotes TNBC cells tumorigenesis. Using microarray analysis of lncRNA expression profiles, we identified a lncRNA SOX2-OT, which is induced by PAI-1 and could function as an oncogenic lncRNA in TNBC. Mechanistic analysis demonstrated that SOX2-OT acts as a molecular sponge for miR-942-5p to regulate the expression of PIK3CA, ultimately leading to activating PI3K/Akt signaling pathway and promoting TNBC metastasis. Taken together, our findings suggest that SOX2-OT regulates PAI-1-induced TNBC cell metastasis through miR-942-5p/PIK3CA signaling and illustrate the great potential of developing new SOX2-OT-targeting therapy for TNBC patients.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  LY294002; Lung and liver metastases; PAI-039; PAI-1/SERPINE1; ceRNA

Mesh:

Substances:

Year:  2022        PMID: 34997317     DOI: 10.1007/s00018-021-04120-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  46 in total

1.  Plasminogen Activator Inhibitor 1 (PAI1) Promotes Actin Cytoskeleton Reorganization and Glycolytic Metabolism in Triple-Negative Breast Cancer.

Authors:  Brock A Humphries; Johanna M Buschhaus; Yu-Chih Chen; Henry R Haley; Tonela Qyli; Benjamin Chiang; Nathan Shen; Shrila Rajendran; Alyssa Cutter; Yu-Heng Cheng; Yu-Ting Chen; Jason Cong; Phillip C Spinosa; Euisik Yoon; Kathryn E Luker; Gary D Luker
Journal:  Mol Cancer Res       Date:  2019-02-04       Impact factor: 5.852

2.  Epithelial-mesenchymal transition induced PAI-1 is associated with prognosis of triple-negative breast cancer patients.

Authors:  Jing Xu; Wenwen Zhang; Lin Tang; Weiwei Chen; Xiaoxiang Guan
Journal:  Gene       Date:  2018-05-23       Impact factor: 3.688

3.  Maintenance of pregnancy in protein-deficient rats with dietary supplements of methionine.

Authors:  W G Kinzey
Journal:  Proc Soc Exp Biol Med       Date:  1970-02

Review 4.  Triple-negative breast cancer: epidemiological considerations and recommendations.

Authors:  P Boyle
Journal:  Ann Oncol       Date:  2012-08       Impact factor: 32.976

5.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis.

Authors:  Antoine E Karnoub; Ajeeta B Dash; Annie P Vo; Andrew Sullivan; Mary W Brooks; George W Bell; Andrea L Richardson; Kornelia Polyak; Ross Tubo; Robert A Weinberg
Journal:  Nature       Date:  2007-10-04       Impact factor: 49.962

6.  Endothelial cells promote triple-negative breast cancer cell metastasis via PAI-1 and CCL5 signaling.

Authors:  Wenwen Zhang; Jing Xu; Hehui Fang; Lin Tang; Weiwei Chen; Qian Sun; Qun Zhang; Fang Yang; Zijia Sun; Lulu Cao; Yucai Wang; Xiaoxiang Guan
Journal:  FASEB J       Date:  2017-09-12       Impact factor: 5.191

Review 7.  Three decades of research on plasminogen activator inhibitor-1: a multifaceted serpin.

Authors:  Paul J Declerck; Ann Gils
Journal:  Semin Thromb Hemost       Date:  2013-03-16       Impact factor: 4.180

8.  Invasion factors uPA/PAI-1 and HER2 status provide independent and complementary information on patient outcome in node-negative breast cancer.

Authors:  Iris Zemzoum; Ronald E Kates; Jeffrey S Ross; Peer Dettmar; Moshumi Dutta; Cordula Henrichs; Suna Yurdseven; Heinz Höfler; Marion Kiechle; Manfred Schmitt; Nadia Harbeck
Journal:  J Clin Oncol       Date:  2003-03-15       Impact factor: 44.544

9.  Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer.

Authors:  Isabell Witzel; Karin Milde-Langosch; Marcus Schmidt; Thomas Karn; Sven Becker; Ralph Wirtz; Achim Rody; Elena Laakmann; Dina Schütze; Fritz Jänicke; Volkmar Müller
Journal:  Onco Targets Ther       Date:  2014-11-28       Impact factor: 4.147

10.  Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis.

Authors:  Esak Lee; Elana J Fertig; Kideok Jin; Saraswati Sukumar; Niranjan B Pandey; Aleksander S Popel
Journal:  Nat Commun       Date:  2014-09-02       Impact factor: 14.919

View more
  3 in total

1.  Comprehensive Analysis of the Prognosis and Drug Sensitivity of Differentiation-Related lncRNAs in Papillary Thyroid Cancer.

Authors:  Wenlong Wang; Ning Bai; Xinying Li
Journal:  Cancers (Basel)       Date:  2022-03-07       Impact factor: 6.639

Review 2.  Post-Transcriptional Modifications of RNA as Regulators of Apoptosis in Glioblastoma.

Authors:  Anton Dome; Maya Dymova; Vladimir Richter; Grigory Stepanov
Journal:  Int J Mol Sci       Date:  2022-08-17       Impact factor: 6.208

Review 3.  Long Noncoding RNAs and Circular RNAs Regulate AKT and Its Effectors to Control Cell Functions of Cancer Cells.

Authors:  Jen-Yang Tang; Ya-Ting Chuang; Jun-Ping Shiau; Kun-Han Yang; Fang-Rong Chang; Ming-Feng Hou; Ammad Ahmad Farooqi; Hsueh-Wei Chang
Journal:  Cells       Date:  2022-09-20       Impact factor: 7.666

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.